Abrdn PLC Galera Therapeutics, Inc. Transaction History

Abrdn PLC

  • $53.3 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024
BUY
$0.09 - $0.27 $80,853 - $242,560
898,374 New
898,374 $125,000

Others Institutions Holding GRTX

# of Institutions
2
Shares Held
909K
Call Options Held
0
Put Options Held
0
View Full List

About Galera Therapeutics, Inc.

GRTX Quotes by TradingView
  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $1.07M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email